![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and Safety of an Interferon-Free Regimen of MK-5172 + Ribavirin for 12 Weeks or 24 Weeks in Treatment-Naive, Noncirrhotic Subjects With HCV GT1 Infection: The C-SPIRIT Study
|
|
|
Reported by Jules Levin
Asian Pacific Association for The Study of the Liver,
Brisbane, Australia
12-15 March, 2014
Edward Gane, Ziv Ben Ari, Lindsay Mollison, Eli Zuckerman, Rafael Bruck, Yaacov Baruch, Janice Wahl, Sanhita Bhanja, Peggy Hwang, Yue Zhao, Michael N. Robertson
![APASL1.gif](../images/031714/031714-14/APASL1.gif)
![APASL2.gif](../images/031714/031714-14/APASL2.gif)
![APASL3.gif](../images/031714/031714-14/APASL3.gif)
![APASL4.gif](../images/031714/031714-14/APASL4.gif)
![APASL5.gif](../images/031714/031714-14/APASL5.gif)
![APASL6.gif](../images/031714/031714-14/APASL6.gif)
![APASL7.gif](../images/031714/031714-14/APASL7.gif)
![APASL8.gif](../images/031714/031714-14/APASL8.gif)
![APASL9.gif](../images/031714/031714-14/APASL9.gif)
![APASL10.gif](../images/031714/031714-14/APASL10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|